Cytomegalovirus (CMV) infection remains a significant complication after hematopoietic
stem cell transplantation (HSCT) and may have a deleterious impact on the overall outcome …

Cytomegalovirus (CMV) is one of the most important pathogens that infect solid organ
transplant recipients. CMV is associated with increased morbidity and mortality in this …

Background. Cytomegalovirus (CMV) disease remains an important problem in solid-organ
transplant recipients, with the greatest risk among donor CMV-seropositive, recipient …

Tumor infiltration by T cells profoundly affects cancer progression and responses to
immunotherapy. However, the tumor immunosuppressive microenvironment can impair the …

Infectious complications remain a leading cause of morbidity and mortality after solid organ
transplantation (SOT), and largely depend on the net state of immunosuppression achieved …

Background. A CD8+ T-cell response to cytomegalovirus (CMV) has been associated with
control of viral replication. Assessment shortly after the onset of asymptomatic viremia could …

In this prospective study we analyzed pretransplant interferon-γ secretion by
cytomegalovirus (CMV)-specific CD8+ T cells to assess its possible utility in determining the …

Background. A simple test to identify recovery of CMV-specific T-cell immunity following
hematopoietic stem cell transplantation (HSCT) could assist clinicians in managing CMV …

Background Cytomegalovirus (CMV) infections in hematopoietic cell transplant (HCT)
recipients cause substantial morbidity and mortality. CMV cell-mediated immunity (CMV …

Background Recurrent cytomegalovirus (CMV) disease in solid organ transplant recipients
frequently occurs despite effective antiviral therapy. We previously demonstrated that …